These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38642004)

  • 1. High expression of AlkB homolog 5 suppresses the progression of non-small cell lung cancer by facilitating ferroptosis through m6A demethylation of SLC7A11.
    Huang Z; Lin G; Hong Y; Weng L; Zhu K; Zhuang W
    Environ Toxicol; 2024 Jul; 39(7):4035-4046. PubMed ID: 38642004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ALKBH5 decreases SLC7A11 expression by erasing m6A modification and promotes the ferroptosis of colorectal cancer cells.
    Luo J; Yu H; Yuan Z; Ye T; Hu B
    Clin Transl Oncol; 2023 Jul; 25(7):2265-2276. PubMed ID: 36820954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ALKBH5 Modulates Asthma Progression by Downregulating N6-methyladenosine Methylation.
    Fan X; Wei C; Han Y
    Iran J Allergy Asthma Immunol; 2024 Apr; 23(2):211-219. PubMed ID: 38822515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N
    Zhu Z; Qian Q; Zhao X; Ma L; Chen P
    Gene; 2020 Mar; 731():144348. PubMed ID: 31927006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m
    Jin D; Guo J; Wu Y; Yang L; Wang X; Du J; Dai J; Chen W; Gong K; Miao S; Li X; Sun H
    Mol Cancer; 2020 Feb; 19(1):40. PubMed ID: 32106857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ALKBH5 inhibits thyroid cancer progression by promoting ferroptosis through TIAM1-Nrf2/HO-1 axis.
    Li W; Huang G; Wei J; Cao H; Jiang G
    Mol Cell Biochem; 2023 Apr; 478(4):729-741. PubMed ID: 36070054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALKBH5 promotes non-small cell lung cancer progression and susceptibility to anti-PD-L1 therapy by modulating interactions between tumor and macrophages.
    Hua X; Xu Q; Wu R; Sun W; Gu Y; Zhu S; Liu X; Lv T; Song Y
    J Exp Clin Cancer Res; 2024 Jun; 43(1):164. PubMed ID: 38872221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The N6-methyladenosine modification enhances ferroptosis resistance through inhibiting SLC7A11 mRNA deadenylation in hepatoblastoma.
    Liu L; He J; Sun G; Huang N; Bian Z; Xu C; Zhang Y; Cui Z; Xu W; Sun F; Zhuang C; Man Q; Gu S
    Clin Transl Med; 2022 May; 12(5):e778. PubMed ID: 35522946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RNA demethylase ALKBH5 prevents pancreatic cancer progression by posttranscriptional activation of PER1 in an m6A-YTHDF2-dependent manner.
    Guo X; Li K; Jiang W; Hu Y; Xiao W; Huang Y; Feng Y; Pan Q; Wan R
    Mol Cancer; 2020 May; 19(1):91. PubMed ID: 32429928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
    Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
    Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_0005615 enhances multiple myeloma progression through interaction with EIF4A3 to regulate MAP3K4 m6A modification mediated by ALKBH5.
    Zhu K; Gou F; Zhao Z; Xu K; Song J; Jiang H; Zhang F; Yang Y; Li J
    Leuk Res; 2024 Jun; 141():107451. PubMed ID: 38663164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IGF2BP3 suppresses ferroptosis in lung adenocarcinoma by m6A-dependent regulation of TFAP2A to transcriptionally activate SLC7A11/GPX4.
    Li P; Chu D; Ding G; Qin D; Bu Y; Tian B
    Mol Cell Biochem; 2024 Jul; ():. PubMed ID: 39026029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FTO Prevents Thyroid Cancer Progression by SLC7A11 m6A Methylation in a Ferroptosis-Dependent Manner.
    Ji FH; Fu XH; Li GQ; He Q; Qiu XG
    Front Endocrinol (Lausanne); 2022; 13():857765. PubMed ID: 35721711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RNA demethylase ALKBH5 inhibits TGF-β-induced EMT by regulating TGF-β/SMAD signaling in non-small cell lung cancer.
    Sun Z; Su Z; Zhou Z; Wang S; Wang Z; Tong X; Li C; Wang Y; Chen X; Lei Z; Zhang HT
    FASEB J; 2022 May; 36(5):e22283. PubMed ID: 35344216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALKBH5 regulates paclitaxel resistance in NSCLC via inhibiting CEMIP-mediated EMT.
    Gao L; Qiao L; Li Y; Jia L; Cui W; Yang J; Wu C; Wang L
    Toxicol Appl Pharmacol; 2024 Feb; 483():116807. PubMed ID: 38199493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis B Virus-Mediated m6A Demethylation Increases Hepatocellular Carcinoma Stemness and Immune Escape.
    Meng Y; Shu Z; Wang X; Hong L; Wang B; Jiang J; He K; Cao Q; Shi F; Wang H; Gong L; Diao H
    Mol Cancer Res; 2024 Jul; 22(7):642-655. PubMed ID: 38546386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B.
    Gong H; Liu L; Cui L; Ma H; Shen L
    Mol Carcinog; 2021 Sep; 60(9):644-657. PubMed ID: 34169564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALKBH5-mediated m
    Hao L; Yin J; Yang H; Li C; Zhu L; Liu L; Zhong J
    Aging (Albany NY); 2021 Jan; 13(3):4045-4062. PubMed ID: 33428593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. m
    Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
    Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of transcription factor TBX5 inhibits the activation of YAP1-TEAD1 pathway to promote ferroptosis in lung cancer cells.
    Ma R; Hu K; Dai S; Wang Y
    Biochem Biophys Res Commun; 2024 Jul; 718():150037. PubMed ID: 38735135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.